|
From
•>>December 2004
Yvonne T. van der Schouw answers
a few questions about this month's emerging research front
in
field of Agricultural Sciences: Agricultural Sciences
Article: Intake of dietary phytoestrogens is low in postmenopausal women in the United States: The Framingham Study
Authors: de Kleijn, MJJ;van der Schouw,
YT;Wilson, PWF;Adlercreutz, H;Mazur, W;Grobbee, DE;Jacques, PF
Journal: J NUTR, 131: (6) 1826-1832, JUN 2001
Addresses:
Univ Utrecht, Julius Ctr Patient Orientated Res, Med Ctr, Utrecht, Netherlands.
Univ Utrecht, Julius Ctr Patient Orientated Res, Med Ctr, Utrecht, Netherlands.
Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA.
Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland.
Folkhalsan Res Ctr, Helsinki, Finland.
Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer USDA, Boston, MA 02111 USA.
|
|

Why do you think your
paper is highly cited?
|

“The paper describes the amount of intake of isoflavones and
lignans, which are compounds regularly found in vegetable food products, which in structure are similar to female sex hormones”
|
|
Phytoestrogens are plant chemicals that are capable of exhibiting
oestrogen-like activity due to their capacity to bind to the
oestrogen receptor and they occur in three main classes: isoflavones,
coumestans, and lignans. Phytoestrogens are found in various plants—including
grains, beans, green vegetables, fruits, nuts, and grasses.
Isoflavones are primarily found in soybeans and soy foods.
Phytoestrogens are considered to act as selective estrogen receptor
modulators (SERMs), with oestrogen agonist as well as antagonist
action. Supplementation with isolated soy protein, containing the
isoflavones genistein and daidzein, reduces serum total and LDL-cholesterol
and triglycerides, in animals as well as in humans. Vascular
reactivity might be improved by supplementation with isolated soy
protein or isoflavones isolated from red clover. Studies indicate
not only a potential for cardiovascular risk reduction, but also
potential applications in the field of breast and prostate cancer.
Evidence in humans is still scarce.
We still know little of effects of regular dietary phytoestrogen
intake. The knowledge we have at this moment stems from studies in
which phytoestrogens were supplemented to the usual diet. Most
supplementation studies have been conducted with soy isoflavones,
whereas the importance of lignans is not yet resolved, although
there might be more important phytoestrogen sources than isoflavones
in Western populations. Research up till now has been focused on
risk factors. Studies into a clinically manifest endpoint are
urgently needed. For epidemiologic studies into the relation between
phyto-oestrogen intake and disease parameters, phytoestrogen intake
can be estimated with several measures, such as biomarkers
(concentrations in urine or blood) or with dietary questionnaires.
The optimal method for estimating intake is not yet clear. Measuring
levels in urine and plasma is difficult, and there are only a few
labs able to do so. Furthermore, these assessments are very
expensive. We were among the first to describe how isoflavone and
lignan intake can be calculated from a food frequency questionnaire
(FFQ).
Does it describe a new discovery or new methodology that's
useful to others?
It describes how phytoestrogen intake can be calculated with data
gathered from a food frequency questionnaire (FFQ), and presents
tables containing the phytoestrogen contents of foods. These tables
were derived from the available literature.
Could you summarize the significance of your paper in layman's
terms?
The paper describes the amount of intake of isoflavones and
lignans, which are compounds regularly found in vegetable food
products, which in structure are similar to female sex hormones. For
that reason they are believed to be good for female health. The
intake of isoflavones and lignans in postmenopausal women
participating in the Framingham Heart Study in the USA is low, only
one to several milligrams per day. In Asian countries, like Japan,
the intake is 40-fold higher, due to the fact that isoflavones occur
in large quantities in soy, which is a major food item in Japan but
not in Western countries.
How did you become involved in this research?
My main research interest is in sex hormones and cardiovascular
disease. The research has extended over the past years from markers
of duration of exposure to endogenous estrogens (age at menopause),
to genetics involved in sex hormone metabolism, and exogenous sex
hormones. As I was originally trained as a nutritionist, I was happy
to find out that our foods contain naturally occurring estrogen-like
substances, which I could study in my epidemiological studies.
Yvonne T. van der Schouw, Ph.D.
Associate Professor of Clinical Epidemiology
Julius Center for Health Sciences and Primary Care
University Medical Center Utrecht
Utrecht, The Netherlands
|
Return to Emerging Research Fronts | Return
to Special Topics main menu
|